Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0CH6Z
|
|||
| Former ID |
DIB009259
|
|||
| Drug Name |
BBR 3576
|
|||
| Synonyms |
Topixantrone; UNII-R40RXC296C; 156090-18-5; R40RXC296C; 5-((2-(dimethylamino)ethyl)amino)-2-(2-((2-hydroxyethyl)amino)ethyl)indazolo[4,3-gh]isoquinolin-6(2h)-one; Topixantrone [USAN:INN:BAN]; 5-((2-(Dimethylamino)ethyl)amino)-2-(2-((2-hydroxyethyl)amino)ethyl)indazolo(4,3-gh)isoquinolin-6(2H)-one; Topixantrone (USAN/INN); AC1Q6OO8; AC1L55WV; SCHEMBL1344518; CHEMBL153774; CTK4C8956; DTXSID30166042; BBR 3576 (DIHYDROCHLORIDE); AKOS030604979; D06190
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Terminated | [1] | |
| Company |
Cell Therapeutics
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H26N6O2
|
|||
| Canonical SMILES |
CN(C)CCNC1=C2C3=C(C=C1)N(N=C3C4=C(C2=O)C=CN=C4)CCNCCO
|
|||
| InChI |
1S/C21H26N6O2/c1-26(2)10-8-24-16-3-4-17-19-18(16)21(29)14-5-6-23-13-15(14)20(19)25-27(17)11-7-22-9-12-28/h3-6,13,22,24,28H,7-12H2,1-2H3
|
|||
| InChIKey |
ZHAKYGFJVGCOAE-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 156090-18-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015071) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.